Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wynca Group, officially known as Zhejiang Xinan Chemical Industrial Group Co., Ltd., is a leading global producer of agrochemicals and silicon-based materials. The company is primarily recognized for its integrated industrial chains in phosphorus-based chemicals, specifically glyphosate, and organosilicon products. Headquartered in China, Wynca provides a wide range of crop protection solutions, including herbicides, insecticides, and fungicides, alongside high-performance silicone materials used in various industrial and medical applications. The company also produces pharmaceutical intermediates, supporting the synthesis of various active pharmaceutical ingredients. Listed on the Shanghai Stock Exchange, Wynca operates with a focus on a circular economy model that links its phosphorus and silicon production lines to improve sustainability and efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wynca Group.